{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:54:45Z","timestamp":1790844885158,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ejmech.2012.01.060","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T17:18:53Z","timestamp":1328635133000},"page":"433-440","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Antimicrobial activity of sulfonamides containing 5-chloro-2-hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold"],"prefix":"10.1016","volume":"50","author":[{"given":"Martin","family":"Kr\u00e1tk\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmila","family":"Vin\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Volkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Buchta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franti\u0161ek","family":"Trejtnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159ina","family":"Stola\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2012.01.060_bib1","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1016\/j.ejmech.2010.07.031","article-title":"Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities","volume":"45","author":"Wang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0190-9622(97)70135-X","article-title":"Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin","volume":"37","author":"Epstein","year":"1997","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2012.01.060_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4065\/74.7.730","article-title":"Trimethoprim-sulfamethoxazole","volume":"74","author":"Smilack","year":"1999","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejmech.2012.01.060_bib4","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejmech.2012.01.060_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1054\/drup.2000.0146","article-title":"Sulfonamide resistance: mechanisms and trends","volume":"3","author":"Sk\u00f6ld","year":"2000","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2012.01.060_bib6","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1128\/AAC.01658-08","article-title":"Tuberculosis and trimethoprim-sulfamethoxazole","volume":"53","author":"Forgacs","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2012.01.060_bib7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/317441","article-title":"Susceptibility testing for mycobacteria","volume":"31","author":"Woods","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2012.01.060_bib8","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmcl.2009.10.009","article-title":"Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c","volume":"19","author":"Carta","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2012.01.060_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bmcl.2010.11.064","article-title":"Inhibition of beta-carbonic anhydrases with ureido-substituted benzenesulfonamides","volume":"21","author":"Pacchiano","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2012.01.060_bib10","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1128\/AAC.00029-10","article-title":"Mycobacterium tuberculosis and sulfamethoxazole susceptibility","volume":"54","author":"Ong","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2012.01.060_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tube.2009.07.002","article-title":"New anti-tuberculosis agents amongst known drugs","volume":"89","author":"Lougheed","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2012.01.060_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.40.3.727","article-title":"Identification of a class of sulfonamides highly active against dihydropteroate synthase from Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium","volume":"40","author":"Chio","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2012.01.060_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0924-8579(94)90025-6","article-title":"Treatment and developmental therapeutics of Mycobacterium avium complex (MAC) infections","volume":"4","author":"Georgiev","year":"1994","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2012.01.060_bib14","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1128\/AAC.49.11.4801-4803.2005","article-title":"New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors","volume":"49","author":"Suling","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2012.01.060_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0732-8893(94)90092-2","article-title":"In\u00a0vitro susceptibility of clinical isolates of Mycobacterium avium and Mycobacterium intracellulare to folate antagonists","volume":"18","author":"Raszka","year":"1994","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2012.01.060_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/clinids\/4.2.326","article-title":"In\u00a0vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria","volume":"4","author":"Wallace","year":"1982","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ejmech.2012.01.060_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0732-8893(87)90165-9","article-title":"In\u00a0vitro susceptibility of Mycobacterium avium complex to antibacterial agents","volume":"8","author":"Davis","year":"1987","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2012.01.060_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ejmech.2006.11.010","article-title":"Synthesis and antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde","volume":"42","author":"Shi","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib19","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.poly.2011.03.033","article-title":"Multi-biofunctional complexes combining antiseptic copper(II) with antibiotic sulfonamide ligands: structural, redox and antibacterial study","volume":"30","author":"Tommasino","year":"2011","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2012.01.060_bib20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/00958971003660416","article-title":"Synthesis, spectral characterization, and antimicrobial studies of metal complexes of the Schiff base derived from [4-amino-N-guanylbenzene sulfonamide] and salicylaldehyde","volume":"63","author":"Sheela","year":"2010","journal-title":"J.\u00a0Coord. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00706-004-0257-8","article-title":"Preparation and characterization of sulfadiazine Schiff base complexes of Co(II), Ni(II), Cu(II), and Mn(II)","volume":"136","author":"El-Baradie","year":"2005","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib22","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.ejmech.2010.03.014","article-title":"Some new biologically active metal-based sulfonamide","volume":"45","author":"Chohan","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib23","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.saa.2006.04.033","article-title":"Metal complexes of Schiff base derived from sulphametrole and o-vanilin. Synthesis, spectral, thermal characterization and biological activity","volume":"66","author":"Mohamed","year":"2007","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.ejmech.2012.01.060_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00044-008-9104-5","article-title":"Effect of derivatization of sulfamethoxazole and trimethoprim with copper and zinc on their medicinal value","volume":"18","author":"Iqbal","year":"2009","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2012.01.060_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/14756360500043257","article-title":"In-vitro antibacterial, antifungal and cytotoxic properties of sulfonamide-derived Schiff\u2019s bases and their metal complexes","volume":"20","author":"Chohan","year":"2005","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/aoc.1807","article-title":"Sulfonamide-derived compounds and their transition metal complexes: synthesis, biological evaluation and X-ray structure of 4-bromo-2-[(E)-{4-[(3,4-dimethylisoxazol-5 yl)sulfamoyl]phenyl} iminiomethyl] phenolate","volume":"25","author":"Chohan","year":"2011","journal-title":"Appl. Organometal. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ardp.200390004","article-title":"Relationship between the structure and antimycobacterial activity of substituted salicylanilides","volume":"1","author":"Waisser","year":"2003","journal-title":"Arch. Pharm. Pharm. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib28","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1016\/j.ejmech.2010.09.040","article-title":"New amino acid esters of salicylanilides active against MDR-TB and other microbes","volume":"45","author":"Kr\u00e1tk\u00fd","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib29","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1016\/j.bmc.2009.04.008","article-title":"New antituberculotics originated from salicylanilides with promising in\u00a0vitro activity against atypical mycobacterial strains","volume":"17","author":"Imramovsk\u00fd","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib30","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bmc.2009.12.055","article-title":"Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains","volume":"18","author":"F\u00e9rriz","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.01.060_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1529-8019.2008.00190.x","article-title":"Local antibiotics in dermatology","volume":"21","author":"Gelmetti","year":"2008","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ejmech.2012.01.060_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/525536","article-title":"Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection","volume":"46","author":"Proctor","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2012.01.060_bib33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(09)61999-1","article-title":"Community-associated meticillin-resistant Staphylococcus aureus","volume":"375","author":"DeLeo","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2012.01.060_bib34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1248\/yakushi1947.78.7_706","article-title":"Studies on halogenosalicylaldehyde. I. Halogenosalicylaldehyde as reagent for primary amines","volume":"78","author":"Tsukamoto","year":"1958","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejmech.2012.01.060_bib35","first-page":"115","article-title":"Quantitative micromethod for drug susceptibility testing of\u00a0mycobacteria in \u0160ul\u00e1s medium","volume":"3","author":"Kaustov\u00e1","year":"1997","journal-title":"Klin. Microbiol. Inf. Lek."},{"key":"10.1016\/j.ejmech.2012.01.060_bib36","unstructured":"Clinical and Laboratory Standards Institute (CLSI), Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Growth Aerobically; Approved Standard \u2013 seventh ed.. http:\/\/www.clsi.org\/source\/orders\/free\/m11a7.pdf (Accessed September 23, 2011)."},{"key":"10.1016\/j.ejmech.2012.01.060_bib37","unstructured":"Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard \u2013 second ed.. http:\/\/www.clsi.org\/source\/orders\/free\/M38-a2.pdf (Accessed September 23, 2011)."},{"key":"10.1016\/j.ejmech.2012.01.060_bib38","unstructured":"Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard \u2013 third ed.. http:\/\/www.clsi.org\/source\/orders\/free\/M27-A3.pdf (Accessed September 23, 2011)."},{"key":"10.1016\/j.ejmech.2012.01.060_bib39","unstructured":"Promega Corporation. (1996). CellTiter 96\u00ae AQueous one solution cell Proliferation assay. US Patent Office, Pat. No. 5,185,450."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T09:09:39Z","timestamp":1561280979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523412000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":39,"alternative-id":["S0223523412000761"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2012.01.060","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}